Miki Tanaka

Miki Tanaka

Auto-generated profile, based on publicly available information

Miki Tanaka

Daiichi Sankyo Healthcare Co., Ltd., Tokyo, Japan

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YIYasuhiro Ishihara
Yasuhiro Ishihara
KIKouichi Itoh
Kouichi Itoh
MTMiki Tanaka
Miki Tanaka
MTMayumi Tsuji
Mayumi Tsuji
TKToshihiro Kawamoto
Toshihiro Kawamoto
TYTakeshi Yamazaki
Takeshi Yamazaki
Several studies have shown that docosahexaenoic acid (DHA) attenuates epileptic seizures; however, the molecular mechanism by which it achieves this effect is still largely unknown. DHA stimulates the retinoid X receptor, which reportedly regulates the expression of cytochrome P450 aromatase (P450arom). This study aimed to clarify how DHA suppresses seizures, focusing on the regulation of 17β-estradiol synthesis in the brain. Dietary supplementation with DHA increased not only the expression of P450arom, but also 17β-estradiol in the cerebral cortex. While DHA did not affect the duration or scores of the seizures induced by pentylenetetrazole, DHA significantly prolonged the seizure latency. A P450arom inhibitor, letrozole, reduced 17β-estradiol levels and completely suppressed the elongation of seizure latency elicited by DHA. These results suggest that DHA delays the onset of seizures by promoting the synthesis of 17β-estradiol in the brain. DHA upregulated the expression of anti-oxidative enzymes in the cerebral cortex. The oxidation in the cerebral cortex induced by pentylenetetrazole was significantly attenuated by DHA, and letrozole completely inhibited this suppressive action. Thus, the anti-oxidative effects of 17β-estradiol may be involved in the prevention of seizures mediated by DHA. This study revealed that 17β-estradiol in the brain mediated the physiological actions of DHA.

9 February 2018 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
DKDaichi Kita
Daichi Kita
TKTakashi Kinumatsu
Takashi Kinumatsu
AYAtsushi Yokomizo
Atsushi Yokomizo
MTMiki Tanaka
Miki Tanaka
MEMasahiro Egawa
Masahiro Egawa
Atsushi SaitoAtsushi Saito
Atsushi Saito
Objective: This study aimed to evaluate clinically the effect of a novel dentifrice containing three kinds of bactericidal ingredients on periodontal disease. Results: This was a single-arm, prospective clinical study that enrolled patients with periodontitis undergoing supportive periodontal therapy. Periodontal examination, microbiological testing of saliva samples, and evaluation of inflammatory markers (IL-1β, IL-6, IL-8, TNF-α) in gingival crevicular fluid were performed. After 4 weeks of the use of test dentifrice, these parameters were re-evaluated. The use of dentifrice was also subjectively evaluated by clinicians and participants. Among 30 participants, there were significant improvements in the periodontal and microbiological parameters, and the level of interleukin-1β in the gingival crevicular fluid, following the use of the test dentifrice. In clinicians’ subjective evaluation of the overall usefulness of the dentifrice, ‘mild’ and ‘moderate’ improvement accounted for 83% of the total responses. In the participants’ subjective evaluation, the majority indicated their experience of the use as favorable. Within the limitations of this study, it is suggested that the progression of periodontal disease during the supportive periodontal therapy can be prevented by the use of the test dentifrice. Trial registration UMIN Clinical Trials Registry (UMIN-CTR) 000023175. Date of formal registration: July 14, 2016 (https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000026716)

11 August 2026 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
KHKen Hanzawa
Ken Hanzawa
MTMiki Tanaka-Okamoto
Miki Tanaka-Okamoto
MNMatej Nemcic
Matej Nemcic
YMYasuhide Miyamoto
Yasuhide Miyamoto
KNKazuki Nakajima
Kazuki Nakajima